Design of Artificial Human Joints & Organs

Total Page:16

File Type:pdf, Size:1020Kb

Design of Artificial Human Joints & Organs Subrata Pal Design of Artificial Human Joints & Organs Springer Contents 1 Overview of Human System and Its Artificial Replacement 1 1.1 Human Body's Superficial Anatomy 1 1.2 Human Body Features 1 1.3 Body Size, Type, and Proportion 2 1.4 A Brief Outline of the Organization of the Human System 3 1.4.1 Tissue+Tissue=Organ (Different Tissues Together Form an Organ) 3 1.4.2 Organ + Organ=Organ System 4 1.5 Major Organ Systems 4 1.5.1 Integumentary System 5 1.5.2 Muscular System 5 1.5.3 Skeletal System 5 1.5.4 Cardiovascular System 7 1.5.5 Respiratory System 7 1.5.6 Urinary System 7 1.5.7 Reproductive System 9 1.5.8 Nervous System 11 1.5.9 Digestive System 11 1.5.10 Lymphatic System 12 1.5.11 Immune System 12 1.6 Common Names of Internal Organs (in Alphabetical Order) 14 1.7 Brief Idea of Artificial Organs 14 1.7.1 Different Types of Organs 15 1.7.2 Brain 15 1.7.3 Cardia 16 1.7.4 Corpora Cavernosa 16 1.7.5 Ear 16 1.7.6 Eye 16 1.7.7 Heart 17 1.7.8 Limbs 17 1.7.9 Liver 17 vii viii Contents 1.7.10 Lungs 18 1.7.11 Pancreas 18 1.7.12 Bladder 18 1.7.13 Ovaries 18 1.7.14 Beyond Restoration 19 1.7.15 Timeline of Successful Transplants 19 References 20 Exercises 20 2 Mechanical Properties of Biological Materials 23 2.1 Introduction 23 2.2 Structural Versus Material Properties 23 2.2.1 Anisotropy and Nonhomogeneity 24 2.2.2 Viscoelastic Properties 24 2.2.3 Viscosity 25 2.3 Testing Procedures 25 2.4 Bones 26 2.4.1 Composition 26 2.4.2 Structure 27 2.5 Material Properties and Related Behavior 29 2.6 Cartilage , 32 2.6.1 Composition 32 2.7 Material Properties and Related Behavior 33 2.8 Ligaments 34 2.8.1 Composition 34 2.9 Material Properties and Related Behavior 36 2.9.1 Ligaments Have Characteristics of Strain-Rate Sensitivity, Stress-Relaxation, Creep, and Hysteresis 36 2.10 Correlation Between Structure and Function 37 2.10.1 Ligament-Bone/Tendon-Bone Insertions 38 Reading List 39 Problems 39 3 Basics of Design Process 41 3.1 Introduction 41 3.2 Adoptive and Adaptive Design 41 3.2.1 Introduction 41 3.3 Introduction to Machine Design 42 3.4 Principle of Science or Mechanism to Be Used 43 3.5 Safety of Products 47 3.6 Manufacturability 47 3.7 Standardization 48 3.8 Customization 48 For Further Details, the Following Books May Be Consulted 49 Exercises 49 Contents ix 4 Biomaterials and Its Characterization 51 4.1 Introduction 51 4.2 Biomineralization 52 4.3 Abalone Shell 54 4.4 Self-Assembly 55 4.5 Structural Hierarchy 56 4.6 Applications 56 4.7 Compatibility 57 For Further Reading, These Papers May Be Consulted 58 4.8 Biopolymers 59 4.8.1 Applications 60 4.8.2 Sources 60 4.8.3 Applications 60 4.8.4 Sources 60 4.8.5 Applications 61 4.8.6 Benefits 61 4.9 Polymers for Healthcare 62 4.9.1 Sterilization 62 4.9.2 Compatibility with Sterilization Method of Various Industrial Biopolymers (Solviva) 62 4.9.3 Polyether Ether Ketone (PEEK) 63 4.9.4 Applications 64 4.10 Bioceramics 64 4.10.1 History 64 4.10.2 Current Status 65 4.10.3 Future Trends 65 4.11 Bioceramic Materials 65 4.11.1 Bioinert 65 4.11.2 Bioactive 66 4.12 Hydroxyapatite: Medical Uses 66 4.13 Bioactive Glass 67 4.13.1 Compositions 67 4.13.2 Mechanism of Bioactivity 67 4.13.3 Applications 68 For Further Study Consult the Reading List (Ceramics and Glass) 68 4.14 Metals as Biomaterials 69 4.15 Signs of Inferior Tissue Response 71 4.16 Stress-Shielding Phenomena 71 4.17 Shape-Memory Alloy 72 Problems 73 5 Dental Implants: Their Design and Manufacture 75 5.1 Introduction 75 5.1.1 Success Criteria 75 5.2 Anatomy of Human Jawbones 77 5.3 Dental Implants 78 x Contents 5.4 Components of Dental Implant 81 5.5 Types of Implants in Use 81 5.5.1 Subperiosteal Implants 81 5.5.2 Transosteal Implants 82 5.5.3 Endosteal Implants 83 5.5.4 Biocompatibility and Implant Design 84 5.6 Biting Force 86 5.7 Implant Shape 87 5.8 Surface Characteristics 87 5.9 Bone Factors 88 5.10 Loading Conditions 89 5.10.1 Prosthetic Considerations 90 5.10.2 The Type of Prosthetic Reconstruction 90 5.10.3 The Occlusal Scheme 90 5.11 The Number, Distribution, Orientation, and Design of Implants 90 5.12 Placement of Implants into Extraction Sites 91 5.13 Clinical and Biomechanical Considerations for Fixed Tooth Replacement 92 5.13.1 Bone Tissue Factors 92 5.13.2 Soft Tissue Factors 92 5.13.3 Number of Implants 93 5.13.4 Crown-to-Root Ratio 93 5.13.5 Implant Orientation 94 5.14 Advantages of Permanent Tooth Replacement 94 5.15 Manufacture of Implants and Property Enhancement 94 References 95 Problems 96 Glossary of Dental Terminology 96 6 The Design of a Bone Fracture-Fixation Device 101 6.1 Introduction 101 6.2 External Fixation 101 6.2.1 The Ilizarov Apparatus 105 6.3 Internal Fracture Fixation 106 6.3.1 Wires 106 6.3.2 Braided Multifilament Wire 106 6.3.3 Pins 107 6.3.4 Screws 107 6.3.5 Plates 109 6.3.6 Intramedullary Nails Ill 6.3.7 Use of Machine Elements in External Fixators 114 6.4 Other Considerations 114 6.5 Materials Involved in Bone-Plate Design 114 6.6 Composite Materials 115 Contents xi 6.7 Bioactive Fixation Using Bioactive Materials 117 6.8 Compositions 119 6.9 Strong Interfacial Bond with Bone 119 Suggested Study for Fracture Fixation 119 Problems 121 7 The Shoulder Joint and Its Artificial Replacement 123 7.1 Introduction to Joint Replacement 123 7.2 The Shoulder Joint and Its Artificial Replacement 124 7.2.1 Introduction 124 7.2.2 The Different Joints 125 7.2.3 Musculature 126 7.2.4 Ligaments 127 7.2.5 Glenohumeral Joint 127 7.2.6 Glenoid 128 7.2.7 Humerus 128 7.2.8 Kinematics of the Glenohumeral Joint 129 7.2.9 Geometrical Center and Center of Rotation 130 7.3 Humeral Translation Relative to the Scapula 130 7.4 Degrees of Freedom (DOF) 131 7.5 Range of Motion 132 7.6 Total Shoulder Replacement (Glenohumeral Arthroplasty) 134 7.6.1 Reasons for Shoulder Arthroplasty 134 7.7 Types of Shoulder Prostheses 135 7.8 Fully Constrained Type 136 7.9 Nonconstrained Type 138 7.10 Fixation Procedures 143 7.11 Causes of Failure 144 7.11.1 Loosening of the Component 145 7.11.2 Anterior Instability 146 7.11.3 Superior Instability 146 7.11.4 Posterior Instability 146 7.11.5 Inferior Instability 146 7.11.6 Rotator Cuff Tears 146 7.11.7 Intraoperative Fractures 147 7.11.8 Infection 147 7.11.9 Neural Injuries 147 References 147 Problems 148 8 The Elbow Joint and Its Artificial Replacement 149 8.1 Introduction 149 8.1.1 Movements 149 8.2 Muscles, Arteries, and Nerves 151 8.3 Parts of the Joint 151 8.4 Ligaments 152 xii Contents 8.5 Synovial Membrane 152 8.6 Carrying Angle 153 8.7 Diseases of the Elbow 153 8.7.1 Tendonitis 153 8.7.2 Fractures 153 8.7.3 Arthritis 153 8.8 Elbow Replacement 154 8.9 Elbow Replacement Surgery 156 8.10 Life Expectancy of Prosthetic Elbow Joint 156 References 157 Problems 157 9 The Wrist Joint and Its Artificial Replacement 159 9.1 Anatomy 159 9.2 Rheumatoid Arthritis of the Hand and Wrist 159 9.3 Treatment 161 9.3.1 Forces Generated in the Wrist Joint 161 9.4 Implants: Components of a Wrist Arthroplasty 163 9.5 Surgery 164 9.6 Postsurgical Care 165 References 165 Problems 166 10 The Finger Joint and Its Artificial Replacement 167 10.1 Introduction 167 10.2 Diseases of the Finger Joint 168 10.2.1 Symptoms 170 10.2.2 Nonsurgical Treatment 171 10.3 Finger Joint Replacement 171 10.3.1 Introduction 171 Problems 174 References 175 11 The Hip Joint and Its Artificial Replacement 177 11.1 Introduction 177 11.2 Anatomy of the Hip Region 177 11.2.1 Articulation 177 11.2.2 Femoral Neck Angle 178 11.2.3 Capsule 180 11.2.4 Ligaments 180 11.2.5 Blood and Nerve Supply 181 11.2.6 Muscles and Movements 181 11.3 Hip Joint Replacement 182 11.3.1 History 184 11.4 Modern Developments 185 11.5 Costs 186 xiii 11.6 Aseptic Loosening of Hip Prosthesis 186 11.7 Techniques of Surgery 187 11.8 Alternatives to Hip Replacement 187 11.8.1 Apollo Hip System: Simple, Straight-Stem Design for the Low-Demand Patient 188 11.8.2 Dr. K. H. Sancheti's Hip Prosthesis 190 11.9 Design Modification Using Hollow Section 191 11.9.1 Stress Shielding 191 11.9.2 Hollow Design 192 References & Reading List 193 Problems 194 The Knee Joint and Its Artificial Replacement 195 12.1 Anatomy 195 12.1.1 Cruciate Ligaments 195 12.1.2 Anterior Cruciate Ligament 196 12.1.3 Action of Muscles 197 12.1.4 Knee Joint Stabilization 197 12.2 Knee Replacement, or Knee Arthroplasty 199 12.2.1 Introduction 199 12.3 History 200 12.3.1 Technique 201 12.4 Variations in Design 202 12.4.1 Partial Knee Replacement 202 12.5 Risks and Complications 203 12.5.1 Loss of Motion 204 12.5.2 Instability 204 12.5.3 Infection 204 12.6 Developmental Work on a Congruent Tibial Component 205 12.6.1 This Design has Two Advantages 207 12.6.2 Disadvantages 208 12.7 Indian Effort 208 References..
Recommended publications
  • Procedure Code List Effective Jan. 1, 2020 for Preauthorization for Blue Cross and Blue Shield of New Mexico Medicare Advantage Members Only
    Procedure Code List Effective Jan. 1, 2020 for Preauthorization for Blue Cross and Blue Shield of New Mexico Medicare Advantage Members only Beginning Jan. 1, 2020, providers will be required to obtain preauthorization through Blue Cross and Blue Shield of New Mexico (BCBSNM), Optum, or eviCore for certain procedures for Blue Cross Medicare Advantage members as noted in the MAPD Benefit Preauthorization Procedure Code List, Effective 1/1/2020, below. For members NOT attributed to Optum, preauthorization should be obtained from BCBSNM unless the applicable entry in the MAPD Benefit Preauthorization Procedure Code List references eviCore. For members attributed to Optum, preauthorization should be obtained from Optum, even if the applicable entry in the MAPD Benefit Preauthorization Procedure Code List references eviCore. Any entry that references eviCore should be preauthorized through eviCore except for members attributed to Optum. The member's ID Card will indicate that the member is attributed to Optum. Services performed without benefit preauthorization may be denied for payment in whole or in part, and you may not seek reimbursement from members. Member eligibility and benefits should be checked prior to every scheduled appointment. Eligibility and benefit quotes include membership status, coverage status and other important information, such as applicable copayment, coinsurance and deductible amounts. It is strongly recommended that providers ask to see the member's ID card for current information and a photo ID to guard against medical identity theft. A referral to an out-of-plan or out-of-network provider which is necessary due to network inadequacy or continuity of care must be reviewed by the BCBSNM Utilization Management or DMG (if the member is attributed to DMG this information will be reflected on the ID card) prior to a BCBSNM patient receiving care.
    [Show full text]
  • PT/OT Therapy Intake Form Required for All MSK Conditions (Including Hand) Please Use This Fax Form for NON-URGENT Requests Only
    Musculoskeletal Program: PT/OT Therapy Intake Form Required for all MSK Conditions (Including Hand) Please use this fax form for NON-URGENT requests only. Failure to provide all relevant information may delay the determination. Phone and fax numbers may be found on eviCore.com under the Guidelines and Forms section. You may also log into the provider portal located on the site to submit an authorization request. URGENT (same day) REQUESTS MUST BE SUBMITTED BY PHONE Previous Reference/Auth Number (If Continued Care): Date of Submission: Place of Service: ****** Note: This is REQUIRED for WellCare Submissions ******* Service Type Requested: Physical Therapy Occupational Therapy First Name: MI: Last Name: Member ID: DOB (mm/dd/yyyy): Gender: Male Female Street Address: Apt #: City: State: Zip: PATIENT Home Phone: Cell Phone: Primary: Home Cell Member Health Plan/Insurer: First Name: Last Name: Primary Specialty: TIN: NPI: Physician Phone: Physician Fax: Address: Suite #: City: State: Zip: PROVIDER Office Contact: Ext: Email: Diagnoses: Code Description Code Description Start Date for this Request: This is a (select the most appropriate): New condition not previously treated Same/previous condition Date of initial evaluation: Date of onset of condition: Date of current findings: Primary Treatment Area: Spine: Cervical / Upper Thoracic Lower Thoracic / Lumbar / Pelvis Upper Extremity: Shoulder / Arm Elbow / Wrist / Forearm Hand Lower Extremity: Hip / Thigh Knee Ankle / Foot Other: Pelvic Pain / Incontinence Secondary Treatment Area: Spine:
    [Show full text]
  • MAP Preauthorization List EFF: 8/1/2017 (Updated 8/24/17)
    MAP Preauthorization List EFF: 8/1/2017 (Updated 8/24/17) CPT, HCPCS Description Comment or Revenue Code Revenue Codes 0100 All inclusive room and board plus ancillary 0101 All inclusive room and board 0110 Room and Board Private (one bed) 0111 Room and Board Private (one bed) - Medical/Surgical/GYN 0113 Room and Board Private (one bed) - Pediatric 0117 Room and Board Private (one bed) - Oncology 0118 Room and Board Private (one bed) - Rehab 0119 Room and Board Private (one bed) - Other 0121 Room and Board Semiprivate (two beds) - Medical/Surgical/GYN 0123 Room and Board Semiprivate (two beds) - Pediatric 0127 Room and Board Semiprivate (two beds) - Oncology 0128 Level 1 Rehab 0129 Level 2 Rehab - acute complex 0130 Room & Board - Three and Four Beds General Classification 0131 Room & Board - Three and Four Beds Medical/Surgical/Gyn 0133 Room & Board - Three and Four Beds Pediatric 0137 Room & Board - Three and Four Beds Oncology 0138 Room & Board - Three and Four Beds Rehabilitation 0139 Room & Board - Three and Four Beds Other 0140 Room & Board - Deluxe Private General Classification 0141 Room & Board - Deluxe Private Medical/Surgical/Gyn 0143 Room & Board - Deluxe Private Pediatric 0147 Room & Board - Deluxe Private Oncology 0148 Room & Board - Deluxe Private Rehabilitation 0149 Room & Board - Deluxe Private Other 0150 Room & Board - Ward General Classification 0151 Room & Board - Ward Medical/Surgical/Gyn 0153 Room & Board - Ward Pediatric 0157 Room & Board - Ward Oncology 0158 Room & Board - Ward Rehabilitation 0159 Room & Board -
    [Show full text]
  • 114.3 Cmr: Division of Health Care Finance and Policy Ambulatory Care
    114.3 CMR: DIVISION OF HEALTH CARE FINANCE AND POLICY AMBULATORY CARE 114.3 CMR 40.00: RATES FOR SERVICES UNDER M.G.L. c. 152, WORKERS’ COMPENSATION ACT Section 40.01: General Provisions 40.02: General Definitions 40.03: Service and Rate Coverage Provisions 40.04: Provisions Affecting Eligible Providers 40.05: Policies for Individual Service Types 40.06: Fees 40.07: Appendices 40.08: Severability 40.01: General Provisions (1) Scope, Purpose and Effective Date. 114.3 CMR 40.00 governs the payment rates effective April 1, 2009 for purchasers of health care services under M.G.L. c. 152, the Workers’ Compensation Act. Payment rates for services provided by hospitals are set forth in 114.1 CMR 41.00. Program policies relating to medical necessity and clinical appropriateness are determined pursuant to M.G.L. c. 152 and 452 CMR 6.00. (2) Coverage. The payment rates set forth in 114.3 CMR 40.06 are full payment for services provided under M.G.L. c. 152, § 13, including any related administrative or overhead costs. The insurer, employer and health care service provider may agree upon a different payment rate for any service set forth in the fee schedule in 114.3 CMR 40.00. No employee may be held liable for the payment for health care services determined compensable under M.G.L. c. 152, § 13. (3) Administrative Bulletins. The Division may issue administrative bulletins to clarify substantive provisions of 114.3 CMR 40.00, or to publish procedure code updates and corrections. For coding updates and correction, the bulletin will list: (a) new code numbers for existing codes, with the corresponding cross references between existing and new codes numbers; (b) deleted codes for which there are no corresponding new codes; and (c) codes for entirely new services that require pricing.
    [Show full text]
  • Artificial Finger Joint Replacement Due to a Giant Cell Tumor of the Tendon Sheath with Bone Destruction: a Case Report
    3502 ONCOLOGY LETTERS 10: 3502-3504, 2015 Artificial finger joint replacement due to a giant cell tumor of the tendon sheath with bone destruction: A case report HUI LU, HUI SHEN, QIANG CHEN, XIANG-QIAN SHEN and SHOU-CHENG WU Department of Hand Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China Received October 24, 2014; Accepted September 25, 2015 DOI: 10.3892/ol.2015.3813 Abstract. The current study presents the case of a 25-year-old excised completely and the function of the joints was recov- male who developed tumor recurrence of the proximal ered. phalange of the ring finger on the right hand 4 years after partial tumor resection surgery. An X-ray of the right hand Case report showed that the distal bone of the proximal phalange on the ring finger was destroyed. An artificial finger joint replace- A 25-year-old male was admitted to The First Affiliated ment was performed using a silicone joint for this unusual Hospital, College of Meicine, ZheJiang University (Hangzhou, tumor recurrence. The pathological findings were indicative of Zhejiang, China) with tumor recurrence of the proximal a giant cell tumor of the tendon sheath. As a result of surgery, phalange of the ring finger on the right hand 4 years after the patient's proximal interphalangeal point motion recovered partial tumor resection surgery. The patient had no history to the pre-operative level. The pre-operative and post-operative of trauma or infection and was previously healthy. A physical disabilities of the arm, at shoulder and hand and total activity examination revealed swelling of the proximal phalange of the measurement values were 1.67 and 3.33, and 255 and 243˚, finger without clear cause, multiple nodules in the local areas respectively.
    [Show full text]
  • MAP Prior Authorization List EFF: 11/01/2017 (Updated 11/7/2017)
    MAP Prior Authorization List EFF: 11/01/2017 (Updated 11/7/2017) CPT, HCPCS Description Comment or Revenue Code Inpatient All Inpatient admissions require authorization Revenue Codes 0100 All inclusive room and board plus ancillary 0101 All inclusive room and board 0110 Room and Board Private (one bed) 0111 Room and Board Private (one bed) - Medical/Surgical/GYN 0113 Room and Board Private (one bed) - Pediatric 0117 Room and Board Private (one bed) - Oncology 0119 Room and Board Private (one bed) - Other 0121 Room and Board Semiprivate (two beds) - Medical/Surgical/GYN 0123 Room and Board Semiprivate (two beds) - Pediatric 0127 Room and Board Semiprivate (two beds) - Oncology 0130 Room & Board - Three and Four Beds General Classification 0131 Room & Board - Three and Four Beds Medical/Surgical/Gyn 0133 Room & Board - Three and Four Beds Pediatric 0137 Room & Board - Three and Four Beds Oncology 0139 Room & Board - Three and Four Beds Other 0140 Room & Board - Deluxe Private General Classification 0141 Room & Board - Deluxe Private Medical/Surgical/Gyn 0143 Room & Board - Deluxe Private Pediatric 0147 Room & Board - Deluxe Private Oncology 0149 Room & Board - Deluxe Private Other 0150 Room & Board - Ward General Classification 0151 Room & Board - Ward Medical/Surgical/Gyn 0153 Room & Board - Ward Pediatric 0157 Room & Board - Ward Oncology 0159 Room & Board - Ward Other 0160 Room & Board - Other General Classification 0164 Other Room & Board - Sterile Environment 0167 Room & Board - Other Self Care 0169 Room & Board - Other Other 0190 General
    [Show full text]
  • 184591/2021/Estt-Ne Hr
    168 184591/2021/ESTT-NE_HR PUSHPAWATI SINGHANIA HOSPITAL & RESEARCH INSTITUTE A MULTISPECIALITY HOSPITAL (formally known as Puspawati Singhania Research Institute for liver,Renal & Digestive Diseases) (w.e.f. 01.04.2020) OPD CHARGES FEES (Rs) SR. NO. CONSULTANT NAME FIRST SUBS. GASTROENTEROLOGY 1PROF.(DR). R.K.TANDON 20001500 2LT. COL. (DR) ARUN KUMAR 12001200 3DR. DINESH SINGHAL 10001000 4DR. MANOJ KUMAR 10001000 5DR. NRIPEN SAIKIA 10001000 6DR. RAJIV BAIJAL 10001000 7DR. RAHUL GUPTA 20002000 8DR. SHUBHAM VATSYA 900900 SURGICAL GASTROENTEROLOGY & LIVER TRANSPLANT 1DR. K.R VASUDEVAN 12001200 2DR. MANOJ GUPTA 10001000 3DR. BHUSHAN P. BHOLA 12001200 NEPHROLOGY 1DR. SANJEEV SAXENA 12001200 2DR. RAVI BANSAL 10001000 3DR. RAJESH GOEL 800800 UROLOGY 1DR. P.P.SINGH 12001200 2DR. JAGDEEP BALYAN 11001100 3DR. A.S.MALHOTRA 11001100 CARDIOLOGIST 1DR. T.S.KLER 10001000 2DR. VINAYAK AGRAWAL 12001200 3DR. AVINASH VERMA 10001000 4DR. S. N. PATHAK 10001000 5DR. ABHINAV AGGARWAL 10001000 CARDIO SURGERY 1DR. BALRAM AIRAN 10001000 2DR. VIJAY MOHAN KOHLI 12501250 3DR GAURAV GUPTA 10001000 NEUROLOGOY 1DR. SHAMSHER DWIVEDEE 20001800 NEURO SURGERY 1DR. SUMIT GOYAL 10001000 ENDOCRINOLOGY 1DR. MONIKA SHARMA 1001000 PULMONOLOGY 1DR. G.C. KHILNANI 15001500 2DR. NEETU JAIN 10001000 G.I SURGERY 1DR. SANJAY CHAUREY 15001500 2DR. RAJEEV KHANNA 12001000 3DR. HARISH KAPILA 15001500 ONCOLOGY (SURGERY) 1DR. ARVIND KUMAR 15001500 2DR. SALEEM NAYAK 15001500 3DR. VIVEK GUPTA 15001500 4DR. VIKRANT SHARMA 15001500 ONCOLOGY 1DR. AMISH VORA 15001500 2DR. AMIT UPADHYAY 15001500 ORTHOPEDICS 1DR. P.P. KOTWAL 15001500 2DR. GAURAV PRAKASH BHARDWAJ 12001200 Page 1 169 184591/2021/ESTT-NE_HR 3DR. U.K.SADHOO 12001200 4DR. G.S.TUCKER 12001200 5DR. ANIL MISHRA 10001000 6DR.
    [Show full text]
  • Sentinel Report Cder Mpl1r Wp155
    Disclaimer The following report(s) provides findings from an FDA‐initiated query using Sentinel. While Sentinel queries may be undertaken to assess potential medical product safety risks, they may also be initiated for various other reasons. Some examples include determining a rate or count of an identified health outcome of interest, examining medical product use, exploring the feasibility of future, more detailed analyses within Sentinel, and seeking to better understand Sentinel capabilities. Data obtained through Sentinel are intended to complement other types of evidence such as preclinical studies, clinical trials, postmarket studies, and adverse event reports, all of which are used by FDA to inform regulatory decisions regarding medical product safety. The information contained in this report is provided as part of FDA’s commitment to place knowledge acquired from Sentinel in the public domain as soon as possible. Any public health actions taken by FDA regarding products involved in Sentinel queries will continue to be communicated through existing channels. FDA wants to emphasize that the fact that FDA has initiated a query involving a medical product and is reporting findings related to that query does not mean that FDA is suggesting health care practitioners should change their prescribing practices for the medical product or that patients taking the medical product should stop using it. Patients who have questions about the use of an identified medical product should contact their health care practitioners. The following report contains a description of the request, request specifications, and results from the modular program run(s). If you are using a web page screen reader and are unable to access this document, please contact the Sentinel Operations Center for assistance at [email protected].
    [Show full text]
  • Hand Rehabilitation Current Awareness Newsletter
    1 Hand Rehabilitation Current Awareness Newsletter JANUARY 2016 2 Your Local Librarian Whatever your information needs, the library is here to help. As your outreach librarian I offer literature searching services as well as training and guidance in searching the evidence and critical appraisal – just email me at library @uhbristol.nhs.uk OUTREACH: Your Outreach Librarian can help facilitate evidence-based practise for all in the Orthogeriatrics team, as well as assisting with academic study and research. We can help with literature searching, obtaining journal articles and books, and setting up individual current awareness alerts. We also offer one-to-one or small group training in literature searching, accessing electronic journals, and critical appraisal. Get in touch: [email protected] LITERATURE SEARCHING: We provide a literature searching service for any library member. For those embarking on their own research it is advisable to book some time with one of the librarians for a 1 to 1 session where we can guide you through the process of creating a well-focused literature research and introduce you to the health databases access via NHS Evidence. Please email requests to [email protected] 3 Contents New from Cochrane Database of Systematic Reviews ........................................................................... 4 Abstract .................................................................................................................................................. 4 New Activity in Up-to-Date ....................................................................................................................
    [Show full text]
  • American Association for Hand Surgery | 2015 Annual Meeting 1
    Oral Presentation Abstracts 1. Side-to-side vs. Pulvertaft Extensor Tendon Repair; Biomechanical Study Michael Rivlin, Amir Reza Kachooei, MD, Ali Hosseini, PhD, Kyle Eberlin, MD, Nikola Zivaljevic, MD, Guoan Li, PhD and Chaitanya S. Mudgal, MD Department of Orthopaedics, Massachusetts General Hospital, Harvard University, Boston, MA Introduction: Extensor tendons can be coapted using a weave suture technique to provide tensile strength and repair surface overlap. Pulvertaft (PT) weave is the standard method of extensor tendon repair. However, recently, Brown and colleagues described a side-to-side (STS) tendon repair technique (one weave). This method may compare in speed of repair, while simpler, potentially less bulky and without the need specialized equipment while not compromising repair strengths and tensile properties. We hypothesize that STS is more practical than PT with matching biomechanical characteristics. Materials and Methods: In a biomechanical study on 6 cadaver arms, we harvested 30 extensor tendons including four extensor digitorum communis (EDC) and one extensor indicis proprius (EIP). Three hand surgical fellows with similar backgrounds of training under the same conditions and precise standardized technique performed timed repairs (5 PT and 5 STS per surgeon). Following the repairs, the tendons were passed through a custom made graft sizing guide to determine bulk and the results were expressed as a repaired vs. native diameter ratio. The specimens were then tested for ultimate strength and fatigue properties (Instron Inc., Norwood, MA). Failure type and mechanical properties were recorded and compared to the native tendon portion. Results: The STS technique demonstrated comparable time to repair (average tendon repair STS: 8.16 min vs.
    [Show full text]
  • Surgical Services Referral Guide St
    St. Elizabeth’s Medical Center Surgical Services Referral Guide St. Elizabeth’s Medical Center St. Elizabeth’s Medical Center surgical services are available for elective and emergent procedures from many of Boston’s finest board-certified surgeons who work collaboratively with our highly trained anesthesiologists, nurses, technicians, therapists and aides. Together they provide a comprehensive surgical experience from pre-admission education and preparation through to discharge and follow-up care. St. Elizabeth’s surgeons utilize modern, new ORs and leading-edge technologies, including robotic-assisted surgical techniques. There is a state-of-the-art intensive care unit, among the newest in the region with 24/7 eICU support and dedicated step-down care in a new, all private-bed Cardiac Surgery Unit with a dedicated multidisciplinary cardiovascular care team. St. Elizabeth’s has received numerous quality awards and accreditations for its surgical services, including: • One of Healthgrades America’s 50 Best Hospitals for Cardiac Surgery™ for 4 Years in a Row (2018-2021) • The only hospital in Boston named a Five-Star Recipient for Hip Fracture Treatment in 2021 • Named a TransCarotid Artery Revascularization (TCAR) Center of Excellence by Silk Road Medical, Inc., 2019 • Named by U.S. News World Report a High Performing Hospital in treating heart failure and performing heart bypass in its annual U.S. News’ 2018-2019 High Performing Hospital listing • Earned Center of Excellence accreditation through the American College of Surgeons Metabolic and Bariatric • Surgery Accreditation and Quality Improvement Program (MBSAQIP®) for the Steward Center for Weight Control at St. Elizabeth’s Medical Center • Physicians consistently ranked in U.S.
    [Show full text]
  • Illinois Medicaid Benefit Preauthorization Procedure Code
    Illinois Medicaid Benefit Preauthorization Procedure Code List, Effective 1/1/2021 (Updated 7/1/21) This list includes Current Procedural Terminology (CPT®) and/or Healthcare Common Procedure Coding System (HCPCS) codes related to services/categories for which benefit preauthorization may be required. This list is not exhaustive. The presence of codes on this list does not necessarily indicate coverage under the member benefits contract. Always check eligibility and benefits first, prior to rendering services. Member contracts differ in their benefits. Consult the member benefit Utilization Management Process booklet, or contact a customer service representative to determine coverage for a specific medical service or supply. Note: Green highlighted codes are managed by eviCore healthcare (eviCore). Orange highlighted codes are managed by eviCore for Blue Cross Community Health Plans℠ (BCCHP℠) members and by Prime Therapeutics for Blue Cross Community MMAI (Medicare-Medicaid)℠ members. CPT and HCPCS Codes That May Description of Procedure Code Medical Records Request Information Required Require Prior Authorization 11920 CORRECT SKIN COLOR 6.0 CM/< Pre-operative evaluation, history and physical including functional impairment, and operative report. 01990 SUPPORT FOR ORGAN DONOR Recent history and physical, plan of care, and documentation of medical necessity. 11921 CORRECT SKN COLOR 6.1-20.0CM Pre-operative evaluation, history and physical including functional impairment, and operative report. 11922 CORRECT SKIN COLOR EA 20.0CM Pre-operative evaluation, history and physical including functional impairment, and operative report. 11950 TX CONTOUR DEFECTS 1 CC/< Pre-operative evaluation, history and physical including functional impairment, and operative report. 11951 TX CONTOUR DEFECTS 1.1-5.0CC Pre-operative evaluation, history and physical including functional impairment, and operative report.
    [Show full text]